★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & Healthcare CRISPR Defies COVID-19 as Gene Editing Stocks Continue Their Climb Though many sectors have been whacked by the Coronavirus-related hurdles in 2020, research and development of the gene editing technology…McAlinden Research PartnersMay 13, 2020
